Antiretroviral Activity, Pharmacokinetics, and Safety of MK-8527, an Oral Nucleoside Reverse Transcriptase Translocation Inhibitor, in Adults With HIV-1 Who Had Not Previously Taken Antiretroviral Agents: Results From 2 Open-Label, Phase 1 Studies. (academic.oup.com)

Authors: Carstens RP … Gillespie GL Journal: Clinical Infectious Diseases Published: 2026-05-20 DOI: https://doi.org/10.1093/cid/ciag135